Results 101 to 110 of about 446,603 (195)
Background Recurrent pericarditis is an interleukin‐1–mediated chronic autoinflammatory disease. The phase 3 study RHAPSODY (Rilonacept Inhibition of IL‐1 Alpha and IL‐1 Beta for Recurrent Pericarditis: a Pivotal Symptomatology and Outcomes Study ...
Lucia Trotta +11 more
doaj +1 more source
MORPHOLOGICAL FEATURES OF CONSTRICTIVE PERICARDITIS
The features of pericardial morphology in constrictive pericarditis are described, based on the surgery material, which was obtained from 27 patients aged 5-77 years during pericardectomy.
V. V. Kochmasheva +2 more
doaj
Role of Cardiac MRI and CT in Pericarditis and Pericardial Constriction
Pericardial diseases span a spectrum from acute and recurrent pericarditis to chronic constrictive pericarditis. While echocardiography remains the first-line test in the evaluation of patients with suspected pericardial disease, advanced cardiac imaging
Kazim Baser +6 more
doaj +1 more source
RECURRENT PERICARDITIS IN CHILDREN AND ADOLESCENTS: A LARGE, MULTICENTRIC CASE-SERIES AND IMPLICATIONS FOR THE PEDIATRIC ...
Gattorno M +10 more
core +1 more source
Unraveling Heart Inflammation: Recurrent Myopericarditis Caused by Coxsackie A Virus—A Case Report
Acute recurrent myopericarditis, characterized by the occurrence of a new myopericarditis event following a symptom‐free interval of 4–6 weeks, is relatively rare lacking definitive guidelines for management.
Maisha Maliha +8 more
doaj +1 more source
reservedIntroduction: Acute pericarditis, while generally considered a benign disease, may relapse in a sizable proportion of cases. Although innovative therapies, such as anti-IL1 drugs, have emerged as promising treatment options, the criteria for ...
BOCAJ, IRIS
core
Immunosuppressive therapy prevents development of recurrent pericarditis
OBJECTIVES: This study reviews the clinical outcome of a series of patients with recurrent pericarditis before and after immunosuppressive therapy.
LAVEDER F +5 more
core
Background: Although anti-IL 1 drugs have been proven effective in treating recurrent pericarditis, there is a lack of data about their long-term follow-up. Objectives: To evaluate the percentage of patients with recurrent pericarditis treated with anti-
doaj +1 more source
Sustained Pericarditis Recurrence Risk Reduction With Long‐Term Rilonacept
Background Rilonacept, a once‐weekly interleukin‐1 alpha and beta cytokine trap, reduced pericarditis recurrence in the phase 3 study, RHAPSODY (Rilonacept Inhibition of Interleukin‐1 Alpha and Beta for Recurrent Pericarditis: A Pivotal Symptomatology ...
Massimo Imazio +17 more
doaj +1 more source
Corticosteroids for Acute and Recurrent Idiopathic Pericarditis: Unexpected Evidences
Pericarditis is a common disease, often postviral or “idiopathic,” diagnosed in about 5% of emergency room visits for non-ischemic chest pain. Although pericarditis often occurs as a benign and self-limiting disease, it may present recurrences. The first-
Antonio Perrone +5 more
doaj +1 more source

